BioStar Ventures
Venture capitalPetoskey · 6 people tracked
Find your way into BioStar Ventures
32 people in our graph share verified history with the BioStar Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
BioStar Capital leverages a distinctive team of healthcare clinicians, medical thought leaders, and financial professionals to identify and support medical technology ventures. The firm focuses on companies that can deliver both patient impact and strong financial returns for investors.
Source: firm website, verified Aug 5, 2026.
Team · 6 people
from curated & public directories
What they invest in
from 9 of 10 portfolio companiesHealthtech ×6Biotech ×2Fintech ×2Medical Devices ×2Cybersecurity ×1Deep Tech ×1Developer Tools ×1Hardware ×1
HQs:United States×9
Investments · 10 tracked
founders shown can be your intro pathBy year:2017 · 12015 · 23 dated
Autonomix is developing a catheter-based platform that senses nerve activity in real time and performs targeted transvascular denervation, allowing physicians to map, ablate, and verify nerve signaling during a procedure.
Deep TechHealthtechMedical DevicesThe Woodlands, US
David Robins(Director)Robert Schwartz(Executive Officer)Landy Toth(Chief Technology Officer)Matthew Lourie(Executive Officer)Robert Van Tassel(Executive Officer)Brad Hauser(Chief Executive Officer and President)
HealthtechWakefield, US
Tim A. Fischell(Executive Officer, Director)inKate Rumrill(Executive Officer, Director)Lisa Mastromattei(Executive Officer)Ronald D Bache(Executive Officer, Director)Vartan E. Ghazarossian(Executive Officer, Director)David R. Fischell(Director)
Co-investorsMichigan Capital NetworkGilde HealthcareMAF
Ellipse World develops payment card and smartcard technology aimed at reducing fraud and making digital payments safer for the financial industry and e-commerce.
CybersecurityFintechHardwareCulver City, US
Cyril Lalo(CEO & Founder)inSebastien Pochic(Chief Technology Officer)inGabrielle Levy(Chief Financial Officer)inMike Gaffney(President)inJacques Essebag(Director)
Co-investorsTrousdale VenturesUpfront VenturesUPFRONT
Trice provides real-time payment processing through an embedded API that enables businesses to receive funds instantly without chargeback or reversal concerns.
Developer ToolsFintechSaaS
Doug Yeager(CEO)in
Co-investorsLightspeed Venture PartnersDiagramFINTOP CapitalHealthQuest Capital
Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy.
BiotechHealthtechMedical DevicesMalvern, US
Jeffrey O'Donnell(Executive Officer, Director)Mark Foster(Executive Officer, Director)inRichard Kienzle(Executive Officer, Director)in
BoardAlan Davis(Director)Randy Scott(Director)inGary Kurtzman(Director)
Co-investorsHealthQuest Capital
HealthtechSunnyvale, US
John Pavlidis(Executive Officer, Director)Michael Horzewski(Executive Officer, Director)Michael Pederson(Executive Officer, Director)
BoardDavid McIntyre(Director)Justin Klein(Director)Sami Hamade(Director)
Co-investorsNew Enterprise Associates (NEA)Windham Capital Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Corindus Vascular RoboticsConventus OrthopaedicsEllipse TechnologiesKona Medical
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsAutonomix MedicalNASDAQ: AMIX
Portfolio news
latest coverage across their companies
Ellipse · majorhifi.com · Aug 21, 2026
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Autonomix Medical | 10.5% | $6.54 | Nov 2024 | $790.1K |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has BioStar Ventures made?
- BioStar Ventures has 10 tracked investments, 1 of which have exited.
- What sectors does BioStar Ventures focus on?
- BioStar Ventures focuses on Healthtech, Medical Devices.
- Where is BioStar Ventures located?
- BioStar Ventures is headquartered in Petoskey, US.
Co-investors · 1
Broadview Ventures is an impact investor focused on accelerating the development of technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.
Firms observed investing alongside BioStar Ventures, from public investor directories. Shared companies are the overlap with BioStar Ventures's recorded portfolio.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.